Investigating the anticancer effects of chitosan-NLC-folate nanohybrid loaded with auraptene on A2780 ovarian cancer cells
- 28 August 2024
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 398 (2) , 1895-1903
Abstract
The significant fatality rate associated with ovarian cancer underscores the urgent need for novel therapeutic interventions in this area. The focus of this study was to assess the cytotoxic impact of auraptene nanohybrid chitosan folate on A2780 ovarian cancer cells. A combination of liquid and solid lipids were used to create auraptene-nanostructured lipid carriers. Folic acid was conjugated to chitosan in order to modify the surface. The nanoparticles containing methylene blue were dissolved in deionized distilled water to attach the chitosan-folic acid to the nanoparticles. The resazurin cell viability assay was employed to gauge the cytotoxicity of auraptene on the cells. Real-time PCR was utilized to quantify the expression levels of Bcl-2, Bax, and P53 genes. DLS analysis exposed a spheroidal particle with an approximate diameter of 211 nm. The auraptene nanoparticles did not revealed inhibitory effect on normal cell line (HFF-1) at the concentrations that it was toxic for cancerous cells (A2780). In vitro trials suggested that auraptene nanoparticles trigger apoptosis in A2780 cells in a dose-responsive manner by promoting the expression of pro-apoptotic genes (Bax and P53), while suppressing the expression of the anti-apoptotic gene (Bcl-2). Furthermore, auraptene nanoparticles also heightened the production of reactive oxygen species within the cancerous cells. The notable cytotoxic and lethal influence of auraptene nanoparticles on human ovarian cancer may be attributed to their capacity to generate oxidative stress conditions and induce apoptosis.Keywords
This publication has 35 references indexed in Scilit:
- A review of the pharmacological and therapeutic effects of aurapteneBioFactors, 2019
- Auraptene Inhibits Migration and Invasion of Cervical and Ovarian Cancer Cells by Repression of Matrix Metalloproteinasas 2 and 9 ActivityJournal of Pharmacopuncture, 2018
- Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38Artificial Cells, Nanomedicine, and Biotechnology, 2018
- A review on chitosan and its nanocomposites in drug deliveryInternational Journal of Biological Macromolecules, 2018
- Luteolin induces apoptosis by ROS/ER stress and mitochondrial dysfunction in gliomablastomaCancer Chemotherapy and Pharmacology, 2017
- Auraptene Induces Apoptosis via Myeloid Cell Leukemia 1-Mediated Activation of Caspases in PC3 and DU145 Prostate Cancer CellsPhytotherapy Research, 2017
- Nanolipid carrier-based thermoreversible gel for localized delivery of docetaxel to breast cancerCancer Nanotechnology, 2013
- Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and SenescenceCell, 2012
- Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticlesNanomedicine: Nanotechnology, Biology and Medicine, 2010
- Up-regulation of Bax and endonuclease G, and down-modulation of Bcl-XL involved in cardiotoxin III-induced apoptosis in K562 cellsExperimental & Molecular Medicine, 2006